Min-ran Li | Medicine and Dentistry | Women Researcher Award

Published on by Global Academic Awards

Ms. Min-ran Li | Medicine and Dentistry | Women Researcher Award

Ms. Min-ran Li, The First Affiliated Hospital of Jinan University, China

Dr. Minran Li is the Chief Physician at the Division of Infectious Disease at The First Affiliated Hospital of Jinan University. He earned his M.D. in Internal Medicine from Peking University and has extensive expertise in infectious diseases, particularly nonalcoholic steatohepatitis (NASH) and chronic hepatitis B. His research focuses on discovering noninvasive biomarkers and the molecular mechanisms behind liver diseases. Dr. Li has published numerous articles and has been recognized as a Guangdong High-Level Personnel of Young Talents. πŸ₯πŸ“š

Publication Profile

Scopus

 

Education

Ms. Li holds an M.D. in Internal Medicine (Infectious Disease) from Beijing Peking University, a Master’s in Internal Medicine from Hebei Medical University, and a Bachelor’s in Clinical Medicine. This strong educational foundation has empowered her expertise in infectious diseases, particularly liver-related conditions like NASH (nonalcoholic steatohepatitis) and CHB (chronic hepatitis B).

Work Experience

Currently serving as Chief Physician in the Division of Infectious Diseases at the First Affiliated Hospital of Jinan University, Ms. Li has progressively taken on roles of increasing responsibility, including as Associate Chief Physician at The Fifth Hospital of Shijiazhuang. Her work centers on managing liver diseases and exploring innovative biomarkers.

Research Interests

Her research focuses on discovering noninvasive biomarkers for pathological features of NASH in combination with CHB. Her findings on the role of HIGD1A and fibrosis development in liver disease have been pivotal in identifying therapeutic targets, advancing the understanding of liver disease progression.

Awards and Recognitions

Her dedication has been recognized with honors such as the Guangdong High-Level Personnel of Young Talents Program and the Yangcheng Good Doctor Award, underscoring her excellence in medical research and practice.

Conclusion

Ms. Min-ran Li’s strong academic background, leadership in liver disease research, and national and international recognition make her a strong candidate for the Research for Women Researcher Award.

 

Publication Top Notes

  • Pan, Y. et al. (2024). Overexpression of LAG-3: a potential indicator of low immune function in tuberculosis. Frontiers in Cellular and Infection Microbiology, 14, 1410015. 🦠 (0 citations)
  • Li, M.-R. et al. (2024). The function role of HIGD1A in nonalcoholic steatohepatitis from chronic hepatitis B. Scandinavian Journal of Gastroenterology, 59(4), 445–455. πŸ₯— (0 citations)
  • Li, J.-Z. et al. (2023). Mechanism and Progress of Natural Products in the Treatment of NAFLD-Related Fibrosis. Molecules, 28(23), 7936. 🌿 (0 citations)
  • Li, M.-R. et al. (2023). Clinical Features of Non-Alcoholic Fatty Liver Disease in the Non-Lean Population. Obesity Facts, 16(5), 427–434. πŸ” (1 citation)
  • Pan, Y. et al. (2023). Immune checkpoint inhibitors in cancer patients with COVID-19. Open Life Sciences, 18(1), 20220641. πŸ’‰ (1 citation)
  • Li, J.-Z. et al. (2022). Characteristics and treatment strategies for hepatocellular carcinoma caused by nonalcoholic fatty liver disease. Zhonghua gan zang bing za zhi, 30(12), 1392–1396. πŸ₯ (0 citations)
  • Yang, L. et al. (2022). Progress in research of lipogenesis inhibitors for treatment of nonalcoholic fatty liver disease. World Chinese Journal of Digestology, 30(16), 735–742. 🧬 (1 citation)
  • Li, J.-Z. et al. (2021). The identify role and molecular mechanism of the MALAT1/hsa-mir-20b-5p/TXNIP axis in liver inflammation caused by CHB in patients with chronic HBV infection complicated with NAFLD. Virus Research, 298, 198405. πŸ”¬ (20 citations)
  • Zheng, X.-L. et al. (2021). Effect of optimizing oxygen therapy on multiple organ function and prognosis of patients with COVID-19. Chinese Journal of Pathophysiology, 37(5), 909–914. 🫁 (0 citations)
  • Li, M.-R. et al. (2020). Clinical features of hepatitis B patients at immune-tolerance phase with basal core promoter and/or precore mutations. Journal of Viral Hepatitis, 27(10), 1044–1051. 🦠 (4 citations)

 

 

 

 

Tang Gao | Medicine and Dentistry | Best Researcher Award

Published on by Global Academic Awards

Dr. Tang Gao | Medicine and Dentistry | Best Researcher Award

Huazhong University of Science and Technology Tongji Medical College Affiliated Union Hospital, China

Dr. Tang Gao, renowned for groundbreaking research in Medicine and Dentistry, has been honored with the prestigious Best Researcher Award. His exceptional contributions at Huazhong University of Science and Technology Tongji Medical College Affiliated Union Hospital, China, have significantly advanced healthcare knowledge and patient care. πŸ† Dr. Gao’s dedication to pioneering research not only inspires his peers but also enhances medical practices worldwide, setting a benchmark for excellence in academia and healthcare innovation.

Profile

Google Scholar

Education

Dr. Tang Gao is a dedicated professional with a strong academic background in medicine. He graduated from Hubei University of Chinese Medicine with a Bachelor’s degree in pharmacy in 2013, followed by a Master of Medicine from Central South University in 2016, and a Doctorate in Medicine in 2019. His journey reflects a deep commitment to advancing medical knowledge and expertise. πŸŽ“ Dr. Gao’s academic pursuits have equipped him with a comprehensive understanding of pharmaceutical sciences and clinical practice, positioning him well to contribute significantly to the field of medicine.

Research and work experience

Dr. Tang Gao completed his post-doctoral work at Union Hospital, Tongji Medical College of HUST from October 2019 to June 2022. Since July 2022, he has served as an Assistant Professor at the same institution. His research focuses on [mention specific research interests if known]. With a commitment to advancing medical knowledge and education, Dr. Gao brings a wealth of experience and dedication to his role. πŸŽ“ His contributions to academia and healthcare underscore his passion for bridging theory with practical application in medicine.

Projects

Dr. Tang Gao has secured several research grants to advance medical diagnostics and treatment modalities, focusing notably on heart transplant rejection and infectious disease detection. 🌟 His projects include developing activatable bionic probes targeting macrophages for early heart transplant rejection diagnosis, utilizing smart fluorescence/photoacoustic molecular probes for acute rejection diagnosis, and innovating rapid SARS-CoV-2 antibody detection methods. These efforts are supported by various foundations and institutions, highlighting his contributions to both clinical and research fields. Dr. Gao’s work underscores a commitment to integrating advanced biomedical technologies for improving patient outcomes and healthcare efficacy. 🧬

Academic awards

Dr. Tang Gao has achieved remarkable recognition in the field of medicine, notably earning accolades such as the Outstanding Doctoral Dissertation of Hunan Province and being named among the Outstanding Graduates of the region. His contributions to natural science have been acknowledged with the Second Prize of the Natural Science Award of Hunan Province. Additionally, he has been honored with the Chinese Medical Association Youth Science and Technology Award, highlighting his dedication and innovation in medical research and practice. 🌟 Dr. Gao’s accomplishments underscore his commitment to advancing healthcare and scientific knowledge.

Publications Top Notes